Market Trends Merck gets priority review for Welireg for PPGL (MRK:NYSE)By admin8996erT0allJanuary 27, 2025 Sundry PhotographyThe FDA has accepted Merck’s (NYSE:MRK) supplemental New Drug Application with priority review for its drug Welireg, also known…
